Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression

Journal of Pathology

Volumn 211, Issue 3, 2007, Pages 296-304

  Kuo, S H ^a,b   Chen, L T ^c,d   Wu, M S ^a   Kuo, K T ^a   Yeh, K H ^a,b   Doong, S L ^b   Yeh, P Y ^a,b   Hsu, H C ^a,b   Tzeng, Y S ^a,b   Lin, C W ^a   Lin, J T ^a   Cheng, Andrew A ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BCL10; Clone; DLBCL; H. pylori; MALToma; Stomach

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; DNA; IMMUNOGLOBULIN HEAVY CHAIN; METRONIDAZOLE; OMEPRAZOLE; PROTEIN BCL 10;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL TRIAL; CLONAL VARIATION; COMORBIDITY; COMPLEMENTARITY DETERMINING REGION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DNA SEQUENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERADICATION THERAPY; FEMALE; GASTRECTOMY; GENE AMPLIFICATION; GENE REARRANGEMENT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA CELL; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; STOMACH BIOPSY; STOMACH LYMPHOMA; TREATMENT OUTCOME; TUMOR CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CLONE CELLS; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GENE REARRANGEMENT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; STOMACH DISEASES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846622864     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2117     Document Type: Article

References (39)

1. Du MQ, Isaacson PG. Gastric MALToma: from aetiology to treatment. Lancet Oncol 2002;3:97-104.
2. Isaacson PG, Du MQ. MALToma: from morphology to molecules. Nat Rev Cancer 2004;4:644-653.
3. Isaacson PG, Muller-Hermelink HK, Piris MA, Berger F, Nathwani BN, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). IARC Press: Lyon, 2001; 157-160.
4. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidts, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-1594.
5. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-1355.
6. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumors. Br J Haematol 1998;100:3-14.
7. Morgner A, Miehlke S, Fishbach W, Schmitt W, Muller-Hermelink H, Greiner A, et al. Complete remission of primary high-grade B cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001;19:2041-2048.
8. Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high-grade MALTomas after eradication of Helicobacterpylori. Gut 2001;48:454-460.
9. Chen LT, Lin JW, Shyu RY, Jan CM, Chen CL, Chiang IP, et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-4251.
10. Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALToma. J Natl Cancer Inst 2005;97:1345-1353.
11. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004;22:3491-3497.
12. Yeh KH, Kuo SH, Chen LT, Mao TL, Doong SL, Wu MS, et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 2005;106:1037-1041.
13. Peng H, Du M, Diss TC, Isaacson PG, Pan L. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997;30:425-429.
14. Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastrifis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-810.
15. De Wolf-Peeters C, Achten R. The histogenesis of large-cell gastric lymphomas. Histopathology 1999;34:71-75.
16. Matolcsy A, Nagy M, Kisfaludy N, Kelenyi G. Distinct clonal origin of low-grade MALT-type and high-grade lesions of a multifocal lymphoma. Histopathology 1999;34:6-8.
17. Cabras AD, Candidus S, Fend F, Kremer M, Schulz S, Bordi C, et al. Biclonality of gastric lymphomas. Lab Invest 2001;81:961-967.
18. Cabras AD, Weirich G, Fend F, Nahrig J, Bordi C, Hofler H, et al. Oligoclonality of a "composite" gastric diffuse large B-cell lymphoma with areas of marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Virchows Arch 2002;440:209-214.
19. Kuo SH, Chen LT, Chen CL, Doong SL, Yeh KH, Wu MS, et al. Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALToma. World J Gastroenterol 2005;11:4357-4362.
20. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALToma) of the stomach. Am J Pathol 1990;136:153-164.
21. De Jong D, Boot H, van Heerde P, Hart GA, Taal BG. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997;112:1466-1474.
22. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacterpylori. Lancet 1993;342:575-577.
23. Inagaki H, Okabe M, Seto M, Nakamura S, Ueda R, Eimoto T. AP12-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001;158:699-706.
24. Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993;169:291-295.
25. Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALToma. Am J Pathol 2000;157:1147-1154.
26. Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, et al. B-cell monoclonality precedes the development of gastric MALToma in Helicobacter pylori associated chronic gastritis. Am J Pathol 1998;152:1271-1279.
27. Aiello A, Giardini R, Tondini C, Balzarotti M, Diss T, Peng H, et al. PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALTomas? Histopathology 1999;34:326-330.
28. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1261-1271.
29. Liu H, Ruskone Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, et al. Resistance of t(11; 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39-40.
30. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, etal. T(11;18) is a marker for all stage gastric MALTomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-1294.
31. Starostik P, Greiner A, Schwarz S, Kalla J, Ott G, Muller-Hermelink HK. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002;99:3-9.
32. Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, et al. Exclusive deletion of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999;155:1817-1821.
33. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C, et al. The product of the t(11; 18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000;156:1433-1439.
34. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B-cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45.
35. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, et al. t(11;18)(q21;q21) is associated with advanced mucosa associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-1187.
36. Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F, et al. Variable frequencies of t(11;18)(q21;q21) in MALTomas of different sites: significant association with CagA strains of H pylori in gastric MALToma. Blood 2003;102:1012-1018.
37. Maes B, Demunter A, Peeters B, De Wolf-Peeters C. BCL10 gene mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the AP12-MALT1 fusion is associated with aberrant nuclear BCL10 expression. Blood 2002;99:1398-1403.
38. Du MQ, Peng HZ, Liu H, Hamoudi RA, Diss TC, Willis TG, et al. BCL10 mutation in lymphoma. Blood 2000;95:3885-3890.
39. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, Chang WC, et al. A pathway for TNFalpha-induced Bcl10 nuclear translocation: Bcl10 is upregulated by NFkappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem 2006;281:167-175.